Association of -308G/A polymorphism in the tumor necrosis factor-α gene promoter with susceptibility to development of hantavirus cardiopulmonary syndrome in the Ribeirão Preto region, Brazil

Archives of Virology

Volumn 155, Issue 6, 2010, Pages 971-975

  Borges, Alessandra Abel ^a,b   Donadi, Eduardo Antônio ^c   Campos, Gelse Mazzoni ^a   Moreli, Marcos Lázaro ^a   de Sousa, Ricardo Luiz Moro ^a   Saggioro, Fabiano Pinto ^a   de Figueiredo, Glauciane Garcia ^a   Badra, Soraya Jabur ^a   Deghaide, Neifi Hassan Saloum ^c   Figueiredo, Luiz Tadeu Moraes ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF ALAGOAS   (Brazil)

^c Molecular Immunology Laboratory   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HANTAVIRUS INFECTION; HANTAVIRUS PULMONARY SYNDROME; HEART DISEASE; HUMAN; MALE; MIDDLE AGED; PROMOTER REGION; SYNDROME; VIROLOGY;

ADOLESCENT; ADULT; AGED; BRAZIL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HANTAVIRUS INFECTIONS; HANTAVIRUS PULMONARY SYNDROME; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SYNDROME; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

HANTAVIRUS;

EID: 77953325982     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-010-0655-7     Document Type: Article

References (28)

1. Borges AA, Figueiredo LTM (2008) Mechanisms of shock in hantavirus pulmonary syndrome. Curr Opin Infect Dis 21: 293-297.
2. Borges AA, Campos GM, Moreli ML, Souza RLM, Saggioro FP, Figueiredo GG, Livonesi MC, Figueiredo LTM (2008) Role of mixed Th1 and Th2 serum cytokines on pathogenesis and prognosis of hantavirus pulmonary syndrome. Microbes Infect 10: 1150-1157.
3. Campos GM, Sousa RLM, Badra SJ, Pane C, Gomes UA, Figueiredo LTM (2003) Serological survey of hantavirus in Jardinópolis county, Brazil. J Med Virol 71: 417-422.
4. Enria DA, Briggiler AM, Pini N, Levis S (2001) Clinical manifestations of new world hantaviruses. In: Schmaljohn CS, Nichol ST (eds) Hantaviruses. Springer, Berlin, pp 117-134.
5. Fernández-Mestre MT, Gendzekhadze K, Rivas-Vetencourt P, Layrisse Z (2004) TNF-α-308 allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 64: 469-472.
6. Ferrer JF, Jonsson CB, Esteban E, Galligan D, Basombrio MA, Peralta-Ramos M, Bharadwaj M, Torrez-Martinez N, Callahan J, Segovia A, Hjelle B (1998) High prevalence of hantavirus infection in Indian communities of the Paraguayan and Argentinean Gran Chaco. Am J Trop Med Hyg 59: 438-444.
7. Ferrer CP, Vial CPA, Ferrés GM, Godoy MP, Culza VA, Marco CC, Castillo HC, Umaña CME, Rothhammer EF, Llop RE (2007) Genetic susceptibility to Andes Hantavirus: association between severity of disease and HLA alleles in Chilean patients. Rev Chilena Infectol 24: 351-359.
8. Figueiredo LTM, Moreli ML, Campos GM, Sousa RL (2003) Hantaviruses in São Paulo State, Brazil. Emerg Infect Dis 9: 891-892.
9. Figueiredo LTM, Moreli ML, Borges AA, Figueiredo GG, Badra SJ, Bisordi I, Suzuki A, Capria S, Padula P (2009) Evaluation of an enzyme-linked immunosorbent assay based on Araraquara virus recombinant nucleocapsid protein. Am J Trop Med Hyg 81: 273-276.
10. Kanerva M, Vaheri A, Mustonen J, Partanen J (1998) High-producer allele of tumor necrosis factor-alpha is part of the susceptibility MHC haplotype in severe Puumala virus-indiced nephropathia epidemica. Scand J Infect Dis 30: 532-534.
11. Keen LJ (2002) The extent and analysis of cytokine and cytokine receptor gene polymorphism. Transpl Immunol 10: 143-146.
12. Khaiboullina SF, Morzunov SP, St Jeor SC (2005) Hantaviruses: molecular biology, evolution and pathogenesis. Curr Mol Med 5: 773-790.
13. Knight J (2001) Polymorphisms in tumor necrosis factor and other cytokines as risks for infectious diseases and the septic syndrome. Curr Infect Dis Rep 3: 427-439.
14. Maes P, Clement J, Groeneveld PHP, Colson P, Huizinga TWJ, van Ranst M (2006) Tumor necrosis factor-α genetic predisposing factors can influence clinical severity in nephropathia epidemica. Viral Immunol 19: 558-564.
15. Mäkelä S, Hurne M, Ala-Hoihala I, Mustonen J, Koivisto A, Partanen J, Vapalahti O, Vaheri A, Pasternack A (2001) Polymorphism of the cytokine genes in hospitalized patients with Puumala hantavirus infection. Nephrol Dial Transplant 16: 1368-1373.
16. Mäkelä S, Mustonen J, Ala-Hoihala I, Hurne M, Partanen J, Vapalahti O, Vaheri A, Pasternack A (2002) Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-α(-308) G/A polymorphism. J Infect Dis 186: 843-846.
17. Moreli ML, Sousa RLM, Figueiredo LTM (2004) Detection of Brazilian hantavirus by reverse transcription polymerase chain reaction amplification of N gene in patients with hantavirus cardiopulmonary syndrome. Mem Inst Oswaldo Cruz 99: 633-638.
18. Mustonen J, Partanent J, Kanerva M, Pietila K, Valpalahti O, Pasternack A, Vaheri A (1996) Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int 49: 217-221.
19. Mustonen J, Partanent J, Kanerva M, Pietila K, Valpalahti O, Vaheri A, Pasternack A (1998) Association of HLA B27 with benign clinical course of nephropathia epidemica caused by Puumala hantavirus. Scand J Immunol 47: 277-279.
20. Nichol ST (2001) Bunyaviruses. In: Knipe DM, Howley PM (eds) Fields virology, 4th edn. Lippincott Willians & Wilkins, Philadelphia, pp 1603-1633.
21. Peters CJ, Khan AS (2002) Hantavirus pulmonary syndrome: the new American hemorrhagic fever. Clin Infect Dis 34: 1224-1231.
22. Pini N (2004) Hantavirus pulmonary syndrome in Latin America. Curr Opin Infect Dis 17: 427-431.
23. Saggioro FP, Rossi AM, Duarte MIS, Martin CCS, Alves VAF, Moreli ML, Figueiredo LTM, Moreira JE, Borges AA, Neder L (2007) Hantavirus infection induces a typical myocarditis that may be responsible for myocardial depression and shock in hantavirus pulmonary syndrome. J Infect Dis 195: 1541-1549.
24. Sousa RLM, Moreli ML, Borges AA, Campos GM, Livonesi MC, Figueiredo LTM, Pinto AA (2008) Natural host relationship and genetic diversity of rodent associated hantaviruses in Southeastern Brazil. Intervirology 51: 299-310.
25. Vincent MJ, Quiroz E, Gracia F, Sanchez AJ, Ksiazek TG, Kitsutani PT, Ruedas LA, Tinnin DS, Caceres L, Garcia A, Rollin PE, Mills JN, Peters CJ, Nichols ST (2000) Hantavirus pulmonary syndrome in Panama: identification of novel hantaviruses and their likely reservoirs. Virology 277: 14-19.
26. Wattavidanage J, Carter R, Perera KL, Munasingha A, Bandara S, McGuinness D, Wickramasinghe AR, Alles HK, Mendis KN, Premawansa S (1999) TNF alpha*2 marks high risk of severe disease during Plasmodium falciparum malaria and other infections in Sri Lankans. Clin Exp Immunol 115: 350-355.
27. Wilson AG, Vries N, Pociot F, di Giovine FS, van der Putte LBA, Duff GW (1993) An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177: 557-560.
28. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 94: 3195-3199.